PRPO dropped its Q1 2026 results after the close on May 14, delivering a revenue beat alongside a deeper-than-year-ago loss — the kind of split verdict that leaves investors doing the math on growth versus profitability.
Revenue came in at $6.71M, up 36% from $4.93M in Q1 2025. That is a meaningful acceleration for a micro-cap diagnostics company. But the earnings per share loss widened to -$0.81 from -$0.59 a year ago, meaning the company is spending faster than it is growing. The tension between top-line momentum and a widening cash burn is the central question the print poses.
The borrow market heading into the results offered few alarm signals. Short interest was minimal — just 0.44% of free float — and availability in the lending pool remained loose. Cost to borrow has drifted higher over the past month, roughly 53% above April levels at around 6.7% annualised, but that follows a softening over the past week. The ORTEX short score of 30.9 places PRPO comfortably in the lower half of the short-selling pressure spectrum, suggesting shorts were not crowding the name ahead of the print. The stock had already given back about 6% on the week entering results, closing at $28.60 on May 14.
One dynamic worth watching is the recent vesting of management's 2025 market-based options, disclosed on May 13. When performance options vest after a stock has more than tripled over the past year, the question of insider intentions becomes relevant — particularly given that the only insider trade logged in the past 90 days was a token $531 purchase by the COO. The holder list is tightly concentrated: chairman Richard Sandberg holds 4.2% and has been a consistent buyer over the past year, most recently accumulating shares around $9–$10 in May 2025, a price now well below where the stock trades.
The print is therefore less about whether Precipio can grow revenue — it demonstrably can — and more about whether management can articulate a credible path to narrowing losses as scale increases.
See the live data behind this article on ORTEX.
Open PRPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
